|
|
Caspian Journal of Internal Medicine، جلد ۱۱، شماره Covid ۱۹ Supplement ۱، صفحات ۵۸۳-۵۸۴
|
|
|
| عنوان فارسی |
|
|
| چکیده فارسی مقاله |
|
|
| کلیدواژههای فارسی مقاله |
|
|
| عنوان انگلیسی |
Insomnia drug therapy in COVID-19 patients; a Letter to Editor |
|
| چکیده انگلیسی مقاله |
Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the newly emerging SARS-CoV-2 virus that was first reported in December 2019 and was announced as a pandemic disease on March 11th, according to a World Health Organization (WHO) warning (1). SARS-CoV-2 is mainly transmitted through respiratory droplets and close contact, accordingly, requires treatment in isolation. It has been reported that many patients developed sleep disturbances due to isolation treatment or medication use, which can lead to pathological events and impaired immunity, and need to prescribe hypnotic medications (2). Also, some patients may have taken hypnotic medications before developing COVID-19 and may be dependent on these medications, and now, with the onset of COVID-19 and the addition of new drugs for its treatment, they need to change their hypnotic medications. |
|
| کلیدواژههای انگلیسی مقاله |
Coronavirus, Sleep disorder, Hypnotics and Sedatives, Drug therapy |
|
| نویسندگان مقاله |
| Ali Rismanbaf
Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
|
|
| نشانی اینترنتی |
http://caspjim.com/browse.php?a_code=A-10-1753-1&slc_lang=en&sid=1 |
| فایل مقاله |
فایلی برای مقاله ذخیره نشده است |
| کد مقاله (doi) |
|
| زبان مقاله منتشر شده |
en |
| موضوعات مقاله منتشر شده |
psychiatry |
| نوع مقاله منتشر شده |
Letter to Editor |
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|